netFormulary
 Report : A-Z NHS England items in Formulary 08/03/2021 09:58:04
[Back]
 
Section Status NHS England Name
05.03.01 Formulary MHS England Abacavir Ziagen
05.03.01 Formulary MHS England Abacavir and Lamivudine Kivexa
05.03.01 Formulary MHS England Abacavir and Lamivudine and Zidovudine Trizivir
08.03.04.01 Formulary MHS England Abemaciclib tabs
05.03.03.01 Restricted Use MHS England Adefovir Dipivoxil Hepsera
08.01.05 Formulary MHS England Arsenic Trioxide Trisenox 1mg/ml concentrate for infusion
05.03.01 Formulary MHS England Atazanavir Reyataz
05.03.01 Formulary MHS England Atazanavir sulfate and cobicistat Evotaz
08.02.04 Formulary MHS England Atezolizumab 
08.01.05 Formulary MHS England Avelumab injection
03.04.02 Formulary MHS England Benralizumab Fasenra
05.03.03.02 Formulary MHS England Boceprevir Victrelis
08.01.05 Formulary MHS England Brigatinib Alunbrig
03.04.03 Formulary MHS England C1 Esterase Inhibitor Berinert
08.01.05 Formulary MHS England Cabozantinib Cometriq
10.02.02 Restricted Use MHS England Cannabidiol Epidyolex
08.01.05 Formulary MHS England Cemiplimab 
05.03.01 Formulary MHS England Cobicistat Tybost
08.01.05 Formulary MHS England Dabrafenib caps
05.03.03.02 Formulary MHS England Daclatasvir  Daklinza
08.01.05 Formulary MHS England Dacomitinib Vizimpro
08.01.05 Formulary MHS England Daratumumab injection
08.03.04.02 Formulary MHS England Darolutamide Nubeqa
05.03.01 Formulary MHS England Darunavir Prezista
05.03.01 Formulary MHS England Darunavir and Cobicistat Rezolsta
05.03.03.02 Formulary MHS England Dasabuvir Exviera
05.03.01 Formulary MHS England Didanosine Videx
05.03.01 Formulary MHS England Dolutegravir 
05.03.01 Formulary MHS England Dolutegravir, abacavir & lamivudine Triumeq
03.07 Restricted Use MHS England Dornase Alfa Pulmozyme
05.03.01 Formulary MHS England Efavirenz Sustiva
05.03.03.02 Formulary MHS England Elbasvir/Grazoprevir Zepatier
05.03.01 Formulary MHS England Elvitegravir 
05.03.01 Formulary MHS England Emtricitabine Emtriva
05.03.01 Formulary MHS England Emtricitabine + tenofovir alafenamide Descovy
05.03.01 Formulary MHS England Emtricitabine 200mg, Rilpivirine 25mg and Tenofovir 245mg Eviplera
05.03.01 Formulary MHS England Enfuvirtide Fuzeon
05.03.03.01 Formulary MHS England Entecavir Baraclude
08.01.05 Formulary MHS England Entrectinib Rozlytrek® 100mg and 200mg
08.01.05 Formulary MHS England Eribulin injection
05.03.01 Formulary MHS England Fosamprenavir Telzir
08.01.05 Formulary MHS England Gilteritinib Xospata
05.03.01 Formulary MHS England Indinavir Crixivan
08.01.05 Formulary MHS England Inotuzumab ozogamicin Besponsa
08.02.03 Formulary MHS England Isatuximab injection
05.03.01 Formulary MHS England Lamivudine Epivir
05.03.03.01 Formulary MHS England Lamivudine Zeffix
03.04.03 Formulary MHS England Lanadelumab 
08.01 Formulary MHS England Larotrectinib VITRAKVI
05.03.03.02 Formulary MHS England Ledipasvir and Sofosbuvir Harvoni
08.01.05 Formulary MHS England Lenvatinib Lenvima
05.03.01 Formulary MHS England Lopinavir and Ritonavir Kaletra
08.01 Formulary MHS England Lorlatinib Lorviqua
03.07 Restricted Use MHS England Mannitol inhalation Bronchitol
05.03.01 Formulary MHS England Maraviroc Celsentri
08.01.05 Formulary MHS England Midostaurin Rydapt
05.03.01 Formulary MHS England Nelfinavir Viracept
05.03.01 Formulary MHS England Nevirapine Viramune
08.01.05 Formulary MHS England Niraparib  caps
08.02.04 Formulary MHS England Nivolumab 
14.05.01 Restricted Use MHS England Normal Immunoglobulin Gammaplex
14.05.01 Formulary MHS England Normal immunoglobulin for Intravenous use Privigen
14.05.01 Formulary MHS England Normal immunoglobulin for Subcutaneous use 
08.02.04 Formulary MHS England Ocrelizumab Injection
05.03.03.02 Formulary MHS England Ombitasvir/ paritaprevir/ ritonavir Viekirax
08.03.04.01 Formulary MHS England Palbociclib Ibrance
08.01.05 Formulary MHS England Pertuzumab Perjeta
03.11 Formulary MHS England Pirfenidone Esbriet
03.05.02 Formulary MHS England Poractant Alfa Curosurf
05.03.01 Formulary MHS England Raltegravir Isentress
08.01.05 Formulary MHS England Regorafenib tabs
08.03.04.01 Formulary MHS England Ribociclib tabs
05.03.01 Formulary MHS England Rilpivirine hydrochloride Edurant
05.03.01 Formulary MHS England Ritonavir Norvir
05.03.01 Formulary MHS England Saquinavir Invirase
05.03.03.02 Formulary MHS England Simeprevir Olysio
08.02.04 Formulary MHS England Siponimod Mayzent Tablets
05.03.03.02 Formulary MHS England Sofosbuvir Sovaldi
05.03.03.02 Formulary MHS England Sofosbuvir/velpatasvir/voxilaprevir Vosevi
05.03.01 Formulary MHS England Stavudine Zerit
05.03.03.02 Formulary MHS England Telaprevir Incivo
05.03.01 Formulary MHS England Tenofovir 245mg, Efavirenz 600mg and Emtricitabine 200mg Atripla
05.03.01 Formulary MHS England Tenofovir alafenamide, elvitegravir, cobicistat & emtricitabine Genvoya
05.03.03.01 Formulary MHS England Tenofovir disoproxil Viread
05.03.03.01 Formulary MHS England Tenofovir Disproxil Viread
05.03.01 Formulary MHS England Tenofovir, cobicistat, elvitegravir & emtricitabine Stribild
08.02.04 Formulary MHS England Teriflunomide tabs
08.01.05 Formulary MHS England Tivozanib Capsules
10.01.03 Formulary MHS England Tocilizumab 
08.01.01 Formulary MHS England Treosulfan caps, injection
05.03.01 Formulary MHS England Zidovudine Retrovir
05.03.01 Formulary MHS England Zidovudine and lamivudine